BBNX 8-K 2026-09-17
Beta Bionics, Inc. (BBNX) 8-K dated 2026-09-17 — accession 0001193125-26-393322.
Beta Bionics, Inc. (BBNX) is a medical devices company listed on NASDAQ.
Beta Bionics, Inc. filed a 8-K on 2026-09-17. Accession 0001193125-26-393322.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Not investment advice. The BBNX SEC hub lists recent forms. The stock page is the research view.